Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma
- 1 May 2017
- journal article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 106, 24-37
- https://doi.org/10.1016/j.freeradbiomed.2017.02.015
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation (81502604)
- Shanghai Science and Technology Commission (14140904000)
- Shanghai Jiao Tong University (81450110092)
- Shanghai Hospital Development Center (SHDC12013107)
This publication has 58 references indexed in Scilit:
- Refined and lethalNature Reviews Cancer, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Realgar-induced apoptosis and differentiation in all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cellsInternational Journal of Oncology, 2011
- From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaBlood, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- As 4 S 4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemiaProceedings of the National Academy of Sciences of the United States of America, 2010
- Arsenic trioxide — An old drug rediscoveredBlood Reviews, 2010
- A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemiaProceedings of the National Academy of Sciences of the United States of America, 2009
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Promoting apoptosis as a strategy for cancer drug discoveryNature Reviews Cancer, 2005